论文部分内容阅读
中药“癌灵Ⅰ号”注射液是哈尔滨医科大学附属一院研制的复方抗癌制剂。治疗急性粒细胞性白血病疗效显著，并获得了国家中医药管理局1993年科技进步二等获。我院放射科于1993年6月起，应用“癌灵Ⅰ号”注射液复合化疗药物介入治疗肺癌13例，取得了较好的疗效。现报告如下：材料
The traditional Chinese medicine “Cancer Ling I” injection is a compound anticancer preparation developed by the First Affiliated Hospital of Harbin Medical University. The curative effect of treating acute myelogenous leukemia was remarkable, and obtained the second-class scientific and technological progress of the State Administration of Traditional Chinese Medicine in 1993. The Department of Radiology of our hospital started in June 1993, and used the “Cancer Ling I” injection combined with chemotherapeutic drugs to treat 13 cases of lung cancer, and achieved good results. The report is as follows: